BCR-ABL1-like B-Lymphoblastic Leukemia/Lymphoma Diagnostic Testing Algorithm in a Resource-Limited Setting

被引:0
|
作者
Vergara-Lluri, Maria [1 ]
Takeda, Moe [2 ]
Oberley, Matthew [3 ]
Aye, Le [4 ]
Siddiqi, Imran [1 ]
Hagiya, Ashley [5 ]
Dong, Stephen [6 ,7 ]
Yaghmour, George [8 ,9 ]
Brynes, Russell [10 ]
机构
[1] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90007 USA
[2] Univ Southern Calif, Los Angeles, CA 90007 USA
[3] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA
[4] Univ Southern Calif, Alhambra, CA USA
[5] Univ Southern Calif, Keck Sch Med, Pasadena, CA USA
[6] USC, Keck Hosp, Los Angeles, CA USA
[7] LAC USC Med Ctr, Los Angeles, CA USA
[8] Univ Southern Calif, Jane Anne Nohl Div Hematol, Keck Sch Med, USC Norris Canc Hosp, Los Angeles, CA 90007 USA
[9] Ctr Study Blood Dis, Los Angeles, CA USA
[10] Univ Southern Calif, Arcadia, CA USA
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
1484
引用
收藏
页码:1400 / 1402
页数:3
相关论文
共 50 条
  • [1] \ BCR-ABL1-like B-Lymphoblastic Leukemia/Lymphoma Diagnostic Testing Algorithm in a Resource-Limited Setting
    Vergara-Lluri, Maria
    Takeda, Moe
    Oberley, Matthew
    Aye, Le
    Siddiqi, Imran
    Hagiya, Ashley
    Dong, Stephen
    Yaghmour, George
    Brynes, Russell
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1400 - 1402
  • [2] Laboratory testing in BCR-ABL1-like (Philadelphia-like) B-lymphoblastic leukemia/lymphoma
    Siegele, Bradford J.
    Nardi, Valentina
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (07) : 971 - 977
  • [3] BCR-ABL1-like B-lymphoblastic leukemia/lymphoma: Review of the entity and detection methodologies
    Conant, Joanna L.
    Czuchlewski, David R.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2019, 41 : 126 - 130
  • [4] MUC4 expression by immunohistochemistry is a specific marker for BCR-ABL1+ and BCR-ABL1-like B-lymphoblastic leukemia
    Kaumeyer, Benjamin
    Fidai, Shiraz
    Sukhanova, Madina
    Yap, Kai Lee
    Segal, Jeremy
    Raca, Gordana
    Stock, Wendy
    McNeer, Jennifer
    Lager, Angela M.
    Gurbuxani, Sandeep
    LEUKEMIA & LYMPHOMA, 2022, 63 (06) : 1436 - 1444
  • [5] BCR-ABL1-like B-Lymphoblastic Leukemia/Lymphoma with FOXP1-ABL1 Rearrangement: Comprehensive Laboratory Identification Allowing Tyrosine Kinase Inhibitor Use
    Yenamandra, Ashwini K.
    Kaviany, Saara
    Borinstein, Scott C.
    Friedman, Debra L.
    Kovach, Alexandra E.
    LABORATORY MEDICINE, 2019, 50 (04) : 401 - 405
  • [6] BCR-ABL1 positive lymphoblastic lymphoma - should it be treated like a B-lymphoblastic leukemia with t(9;22);BCR-ABL1?
    Takahashi, Taro
    Ichikawa, Satoshi
    Ichinohasama, Ryo
    Harigae, Hideo
    LEUKEMIA & LYMPHOMA, 2020, 61 (05) : 1265 - 1267
  • [7] Genomic Landscape of Adult and Pediatric BCR-ABL1-Like B-Lymphoblastic Leukemia Using Parallel DNA and RNA Sequencing
    Severson, Eric A.
    Vergilio, Jo-Anne
    Gay, Laurie M.
    Daniel, Sugganth
    Hemmerich, Amanda C.
    Elvin, Julia A.
    Britt, Nicholas
    Nahas, Michelle
    Cohen, Michael B.
    Brown, Charlotte
    Sathyan, Pratheesh
    Rankin, Andrew
    Miller, Vincent
    Ross, Jeffrey S.
    Ramkissoon, Shakti H.
    ONCOLOGIST, 2019, 24 (03): : 372 - 374
  • [8] BCR-ABL1-like acute lymphoblastic leukemia in childhood and targeted therapy
    Cario, Gunnar
    Leoni, Veronica
    Conter, Valentino
    Baruchel, Andre
    Schrappe, Martin
    Biondi, Andrea
    HAEMATOLOGICA, 2020, 105 (09) : 2200 - 2204
  • [9] Diagnostic Utility of CRLF2 Immunohistochemistry in BCR/ABL-Like B-Lymphoblastic Leukemia
    Takeda, Moe
    Chen, Zhengshan
    Siddiqi, Imran
    Vergara-Lluri, Maria
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1394 - 1395
  • [10] Mutational Profile of B-Lymphoblastic Leukemia with BCR::ABL1
    Lai, Xiaoxuan
    Hu, Collin
    Tang, Guilin
    Fang, Hong
    Wang, Wei
    Patel, Keyur
    You, M. James
    Medeiros, L. Jeffrey
    Hu, Shimin
    LABORATORY INVESTIGATION, 2024, 104 (03) : S1438 - S1438